STAT+: Merck to buy Terns Pharmaceuticals in $6.7B deal
On the lookout for its next blockbusters, Merck dropped it would buy Terns Pharmaceuticals, picking up a promising leukemia treatment.
What’s Happening
So get this: On the lookout for its next blockbusters, Merck dropped it would buy Terns Pharmaceuticals, picking up a promising leukemia treatment.
Pharma Pharma STAT Plus: How an outsider crept into Eli Lilly’s top ranks — and plans to drive its business forward By Matthew Herper First Opinion First Opinion The U. (we’re not making this up)
Needs to be worried about Iranian biological materials By Ashish K.
Why This Matters
Medical professionals are taking note of this development.
Health experts are weighing in on what this means for people.
The Bottom Line
This story is still developing, and we’ll keep you updated as more info drops.
Thoughts? Drop them below.
Daily briefing
Get the next useful briefing
If this story was worth your time, the next one should be too. Get the daily briefing in one clean email.
Reader reaction
